Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Deutsche Bank $1 billion notes offering
The fixed-rate senior debt funding notes are due 2029
Screaming Eagle de-SPAC transaction with Lionsgate’s studio business
We advised the placement agents on the de-SPAC transaction and the related PIPE financing
MediaAlpha $144.2 million secondary offering
The Class A common stock is listed on the New York Stock Exchange
Ventas $500 million senior notes offering
We advised Ventas on its investment-grade debt offering
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
NatWest Group $1 billion contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Meritage Homes $575 million convertible notes offering
The 1.75% convertible senior notes are due 2028
SS&C Technologies $750 million senior notes offering
We advised SS&C Technologies on the high-yield debt offering